Evidence map›Paper›PMID 26355014›Full record

ArticleThe American journal of pathology2015

Attenuation of the progression of articular cartilage degeneration by inhibition of TGF-β1 signaling in a mouse model of osteoarthritis.

Rebecca Chen, Michelle Mian, Martin Fu, Jing Ying Zhao, Liang Yang, Yefu Li, Lin Xu

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in The American journal of pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05637216 (A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients), which is not on this map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05637216 phase2active not recruitingnot on this mapstarted 2023, after this paper: background citation

A Pilot Study of Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

TypeinterventionalSponsorShaw Cancer CenterRan2023 to 2027Enrolled43ConditionsRadiation Induced FibrosisArmsLosartan 25 milligram capsule, Placebo
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Sustained-release losartan from peptide nanofibers promotes chondrogenesis.Frontiers in bioengineering and biotechnology · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Frontiers in immunology · 2020
    Article
  16. Article
  17. Review
  18. The TGFβ type I receptor TGFβRI functions as an inhibitor of BMP signaling in cartilage.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  19. [Research progress on signaling molecules involved in articular cartilage repair].Sheng wu yi xue gong cheng xue za zhi = Journal of biomedical engineering = Shengwu yixue gongchengxue zazhi · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Rebecca ChenDepartment of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts.
Michelle MianDepartment of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts.
Martin FuDepartment of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts.
Jing Ying ZhaoDepartment of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts.
Liang YangDepartment of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts.
Yefu LiDepartment of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts; Faculty of Medicine, Harvard Medical School, Boston, Massachusetts. Electronic address: yefu_li@hms.harvard.edu.
Lin XuDepartment of Developmental Biology, Harvard School of Dental Medicine, Boston, Massachusetts; Faculty of Medicine, Harvard Medical School, Boston, Massachusetts. Electronic address: lin_xu@hms.harvard.edu.
Harvard University · US

Funding

Role of DDR2 in OA-like Pathogenesis in OsteochondrodysplasiasR01AR051989 · NIAMS · HARVARD MEDICAL SCHOOL · PI LI, YEFU · 2006 to 2010
$1.5M
NIAMS NIH HHS R01 AR051989
6 · The paper itself

Abstract

Transforming growth factor beta 1 (TGF-β1) is implicated in osteoarthritis. We therefore studied the role of TGF-β1 signaling in the development of osteoarthritis in a developmental stage-dependent manner. Three different mouse models were investigated. First, the Tgf-β receptor II (Tgfbr2) was specifically removed from the mature cartilage of joints. Tgfbr2-deficient mice were grown to 12 months of age and were then euthanized for collection of knee and temporomandibular joints. Second, Tgfbr2-deficient mice were subjected to destabilization of the medial meniscus (DMM) surgery. Knee joints were then collected from the mice at 8 and 16 weeks after the surgery. Third, wild-type mice were subjected to DMM at the age of 8 weeks. Immediately after the surgery, these mice were treated with the Tgfbr2 inhibitor losartan for 8 weeks and then euthanized for collection of knee joints. All joints were characterized for evidences of articular cartilage degeneration. Initiation or acceleration of articular cartilage degeneration was not observed by the genetic inactivation of Tgfbr2 in the joints at the age of 12 months. In fact, the removal of Tgfbr2 and treatment with losartan both delayed the progression of articular cartilage degeneration induced by DMM compared with control littermates. Therefore, we conclude that inhibition of Tgf-β1 signaling protects adult knee joints in mice against the development of osteoarthritis.

Indexed as

AnimalsCartilage, ArticularChondrogenesisDisease Models, AnimalDisease ProgressionFemaleKnee JointLosartanMenisci, TibialMiceMice, Inbred C57BLMice, KnockoutOsteoarthritisProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IILosartanProtein Serine-Threonine KinasesReceptors, Transforming Growth Factor betaReceptor, Transforming Growth Factor-beta Type IITransforming Growth Factor beta1

Identifiers

PMID26355014
PMCPMC4630169
OpenAlexW2117307927

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.